Western blot results revealed CuC treatment inhibited phosphorylation of Akt at Ser473 in LNCaP, T24, and HepG2 cancer cells, while it showed no significant change of pan-Akt (Figure 8A). This evidence concerns the gene AKT1 and cancer.